This course will be discontinued March 24th. Please plan to complete the course by the end of the day if you want to earn continuing education credit for it.
Disclaimer: This activity was originally presented as a LIVE satellite symposium at the 2013 Case Management Society of America (CMSA) Annual Conference & Expo. If you received credit for attending this activity, you are not eligible to receive credit for the online version, but you are welcome to use it as a resource in your practice.
Release Date: September 30, 2013
Expiration Date: September 30, 2014
Online Monograph with interactive questions.
Case Managers, nurses, and other clinicians who are involved in the management of patients with acute coronary syndromes.
Patients who present with and survive an acute coronary event must clear real and significant hurdles in their transition to outpatient care and ongoing prevention of recurrent events. Key components of this ongoing prevention include pharmacotherapy such as antiplatelets.1
Despite robust recommendations and multiple national initiatives to improve adherence to practice guidelines, a 2008 analysis of pharmacy claims found that the number of patients with acute coronary syndromes (ACS) discharged on aspirin is quite high (97%), while the number discharged on P2Y12 inhibitors is significantly lower (73%).2 The number receiving P2Y12 inhibitors on discharge is lower still (<50%) when only medically managed patients are examined.3 This is despite such therapy receiving the highest level of recommendation (Class I) in ACS guidelines jointly published by the American College of Cardiology Foundation (ACCF) and American Heart Association (AHA).1
Alongside these gaps in contemporary practice there now exists a legislative pressure to improve key quality measures in heart care. Over the next several years, hospitals with high readmission rates will begin to have their Medicare reimbursement rates reduced, and Centers for Medicare & Medicaid Services (CMS) regulations specifically single out acute myocardial infarction as an area for improvement.4
For a plurality of reasons, case managers are optimally positioned to not only greatly improve care for ACS patients but they are also positioned to shield their institutions from targeted payment reductions.5,6 This interactive educational activity will provide case managers with the latest data regarding guideline-based care, effective treatment options, and the role of antiplatelet agents in optimizing ACS care. It will also seek to arm case managers with the necessary tools for process improvement to ensure that patients receive the correct medications throughout their hospital stay, upon discharge, and for the appropriate duration of care.
1Jneid H, et al. J Am Coll Cardiol. 2012. 2Alexander JH. Cleve Clin J Med. 2009. 3Amsterdam EA, et al. Am Heart J. 2009. 4Centers for Medicare & Medicaid Services. Available at: http://www.gpo.gov/fdsys/pkg/FR-2012-08-31/pdf/2012-19079.pdf. 5Villanueva T. J Hosp Med. 2010. 6Whelan CT. J Hosp Med. 2010.
At the conclusion of this activity, participants will be able to:
- Examine clinical guidelines and standards of care related to the acute treatment and secondary prevention of an acute coronary syndrome (ACS).
- Differentiate antiplatelet agents used in the acute treatment of and ongoing prevention of ACS.
- Recognize disconnects in the existing continuum of care for patients with ACS, identify patients at the highest risk of these disconnects, and develop strategies for closing gaps in the continuum of ACS care, including pathway development, discharge checklists, and the involvement of additional healthcare providers.
- ACS from Event to Exit: A Review of Advances in Therapy
Charles V. Pollack Jr., MA, MD, FACEP, FAAEM, FAHA, FCPP
- Gaps, Disconnects, and Missed Opportunities: Checking the Pulse of Current Practice
Tomas Villanueva, DO, MBA, FACPE, SFHM
- The Role of the Case Manager in Bridging Transitions of Care
Nancy E. Skinner, RN-BC, CCM
Faculty Information & Disclosures
In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in educational presentations. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
The planners and managers have no financial or other relationship to products or devices with commercial interests related to the content of this CE activity.
To receive a statement of credit, you must:
- Review the full content of the activity.
- Successfully complete the post-test (70% or better). Complete the evaluation at the end of the activity.
- Statements of credit will be issued immediately online upon completion of the post-test/evaluation.
This course is NOT provided by Gannett Education.
In support of improving patient care, Creative Educational Concepts, Inc. is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
This activity is designated for 1.0 contact hour.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1.0 CE contact hour(s). Activity code: H0000608 Approval Number: 20136773.
To claim these CEs, log into your CE Center account at www.ccmcertification.org.
This activity is complimentary.
It is the policy of Creative Educational Concepts, Inc. (CEC) to ensure independence, balance, objectivity, scientific rigor, and integrity in their continuing education activities.
Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all presentation materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CEC for any product or manufacturer identified.
Unlabeled Use Disclosure:
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
Supported by an independent educational grant from AstraZeneca.
Adobe Acrobat Reader
Creative Educational Concepts, Inc.
1792 Alysheba Way. STE. 100
Toll Free 866-360-1717
Fax (866) 226-9650